2. Academic Validation
  3. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells

Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells

  • Science. 2010 Sep 10;329(5997):1345-8. doi: 10.1126/science.1191536.
Anthony E Boitano 1,  Jian Wang,  Russell Romeo,  Laure C Bouchez,  Albert E Parker,  Sue E Sutton,  John R Walker,  Colin A Flaveny,  Gary H Perdew,  Michael S Denison,  Peter G Schultz,  Michael P Cooke
Affiliations

Affiliation

  • 1 Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
PMID: 20688981 DOI: 10.1126/science.1191536
Abstract

Although practiced clinically for more than 40 years, the use of hematopoietic stem cell (HSC) transplants remains limited by the ability to expand these cells ex vivo. An unbiased screen with primary human HSCs identified a purine derivative, StemRegenin 1 (SR1), that promotes the ex vivo expansion of CD34+ cells. Culture of HSCs with SR1 led to a 50-fold increase in cells expressing CD34 and a 17-fold increase in cells that retain the ability to engraft immunodeficient mice. Mechanistic studies show that SR1 acts by antagonizing the Aryl Hydrocarbon Receptor (AHR). The identification of SR1 and AHR modulation as a means to induce ex vivo HSC expansion should facilitate the clinical use of HSC therapy.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z